Jeuveau
About Jeuveau
Jeuveau is a neuromodulator cosmetic injectable developed by Evolus, positioned as a competitor to Botox for reducing wrinkles, with use in medical spas and dermatology clinics worldwide.
Trend Decomposition
Trigger: Launch of Jeuveau and its positioning as a Botox alternative in cosmetic aesthetics.
Behavior change: Consumers opt for non surgical wrinkle reduction treatments and researchers/clinics standardize Jeuveau usage in aesthetic protocols.
Enabler: Clinical data supporting efficacy and safety, plus broader access through cosmetic clinics and trained professionals.
Constraint removed: Perceived lack of competition in neuromodulators and increased availability through chain clinics.
PESTLE Analysis
Political: Regulatory approvals for cosmetic neuromodulators and ongoing post market surveillance.
Economic: Growing demand for non invasive cosmetic procedures and competitive pricing in clinics.
Social: Rising acceptance of cosmetic treatments and emphasis on aging less visibly.
Technological: Advances in neurotoxin formulations, delivery methods, and practitioner training.
Legal: Compliance frameworks for medical aesthetics and advertising claims.
Environmental: Minimal direct environmental impact; emphasis on waste management in medical settings.
Jobs to be done framework
What problem does this trend help solve?
Reduce the appearance of wrinkles and facial lines non surgically.What workaround existed before?
Surgical alternatives or other cosmetic procedures with longer downtime.What outcome matters most?
Speed of results, reliability of effect, and safety/certainty.Consumer Trend canvas
Basic Need: Personal appearance and confidence enhancement.
Drivers of Change: Demand for quick, minimally invasive aesthetic options; brand competition in neuromodulators.
Emerging Consumer Needs: Transparent pricing, quick appointment availability, natural looking results.
New Consumer Expectations: Clear information about duration, risks, and aftercare.
Inspirations / Signals: High clinician training standards and patient testimonials.
Innovations Emerging: Improved formulation stability and standardized dosing guidelines.
Companies to watch
- Evolus - Developer of Jeuveau; primary market creator and sponsor of clinical data.
- Ideal Image - Large U.S. med spa network offering Jeuveau injections.
- SkinSpirit - Dermatology focused practice group providing neuromodulator treatments including Jeuveau.
- Art of Skin MD - Aesthetic clinic offering Jeuveau among other injectables.
- SkinCare Physicians - Dermatology practice known to offer Jeuveau injections.